Andersen K, Liljefors T, Hyttel J, Perregaard J
Research Department, H. Lundbeck A/S, Copenhagen, Denmark.
J Med Chem. 1996 Sep 13;39(19):3723-38. doi: 10.1021/jm960159f.
Conformationally flexible analogues of the atypical antipsychotic sertindole (1-[2-[4-[5-chloro -1-(4-fluorophenyl)-1H-indol-3-yl]-4-piperidinyl]ethyl]-2-imidazolidi non e) were synthesized. Replacement of the 4-piperidinyl ring in sertindole by a 2-(methylamino)ethoxy group or a 2-(methylamino)ethyl group (e.g. 1-[2-[2-[5-chloro-1-(4-fluorophenyl)-1H -indol-3-yloxy]ethyl-methylamino]ethyl]-2-imidazolidinone and 1-[3-[[2-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl] -ethyl]methylamino]propyl]-2-imidazolidinone results in binding affinities for serotonin 5-HT2A and dopamine D2 receptors, as well as alpha 1 adrenoceptors, which are very similar to those of sertindole. (Methylamino)alkyl groups of other chain lengths, 3-(methylamino)propyloxy groups, and 2-(methylamino)ethylsulfanyl groups do not have such properties. The capability of the 2-(methylamino)ethoxy group and the 2-(methylamino)ethyl group to replace the 4-piperidinyl ring in sertindole is reflected in molecular modeling studies using recently published receptor-interaction models for 5-HT2 and D2 receptors. Structure-affinity investigations concerning the substituents in the indole nucleus and the 2-imidazolidinone ring system in the 2-(methylamino)ethoxy and the 2-(methylamino)ethyl analogues of sertindole have led to high affinity serotonin 5-HT2A receptor antagonists with selectivity versus dopamine D2 receptors and alpha 1 adrenoceptors (e.g. 1-[2-[[2-[6-chloro-1-(4-fluorophenyl) -1H-indol-3-yloxy]ethyl]methylamino]-ethyl]-2-imidazolidinone and 1-[3-[[2-[6-chloro-1-(4-fluorophenyl) -1H-indol-3-yl]ethyl]methylamino]propyl]-2-imidazolidinone). The latter derivative has also high selectivity for 5-HT2A receptors versus serotonin 5-HT2C receptors. Replacement of the basic amino group by nitrogen-containing six-membered rings has led to 5-chloro-1-(4-fluorophenyl)-3-[(4-methylpiperazinyl)-ethoxy]-1H-in dole, which has high affinity for dopamine D2, versus low affinity for serotonin 5-HT2A receptors and alpha 1 adrenoceptors.
合成了非典型抗精神病药物舍吲哚(1-[2-[4-[5-氯-1-(4-氟苯基)-1H-吲哚-3-基]-4-哌啶基]乙基]-2-咪唑烷酮)的构象柔性类似物。用2-(甲氨基)乙氧基或2-(甲氨基)乙基取代舍吲哚中的4-哌啶基环(例如1-[2-[2-[5-氯-1-(4-氟苯基)-1H-吲哚-3-基氧基]乙基-甲氨基]乙基]-2-咪唑烷酮和1-[3-[[2-[5-氯-1-(4-氟苯基)-1H-吲哚-3-基]乙基]甲氨基]丙基]-2-咪唑烷酮),其对5-羟色胺5-HT2A和多巴胺D2受体以及α1肾上腺素能受体的结合亲和力与舍吲哚非常相似。其他链长的(甲氨基)烷基、3-(甲氨基)丙氧基和2-(甲氨基)乙硫基不具有此类性质。在使用最近发表的5-HT2和D2受体的受体相互作用模型的分子模拟研究中,体现了2-(甲氨基)乙氧基和2-(甲氨基)乙基取代舍吲哚中4-哌啶基环的能力。对舍吲哚的2-(甲氨基)乙氧基和2-(甲氨基)乙基类似物中吲哚核和2-咪唑烷酮环系统中的取代基进行的结构-亲和力研究,得到了对5-羟色胺5-HT2A受体具有高亲和力、对多巴胺D2受体和α1肾上腺素能受体具有选择性的拮抗剂(例如1-[2-[[2-[6-氯-1-(4-氟苯基)-1H-吲哚-3-基氧基]乙基]甲氨基]-乙基]-2-咪唑烷酮和1-[3-[[2-[6-氯-1-(4-氟苯基)-1H-吲哚-3-基]乙基]甲氨基]丙基]-2-咪唑烷酮)。后一种衍生物对5-HT2A受体相对于5-羟色胺5-HT2C受体也具有高选择性。用含氮六元环取代碱性氨基得到了5-氯-1-(4-氟苯基)-3-[(4-甲基哌嗪基)-乙氧基]-1H-吲哚,其对多巴胺D2具有高亲和力,而对5-羟色胺5-HT2A受体和α1肾上腺素能受体具有低亲和力。